Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX
Ivelisse Cruz‐Torres(University of Montana), Paco S. Herson(University of Colorado Anschutz Medical Campus)
Cited by 29
Related Papers
TRPM2 and CaMKII Signaling Drives Excessive GABAergic Synaptic Inhibition Following Ischemia
|Journal of Neuroscience|2024|12